A. Alhazmi et al., EFFECTIVENESS AND COMPLICATIONS OF MITOMYCIN-C USE DURING PEDIATRIC GLAUCOMA SURGERY, Ophthalmology (Rochester, Minn.), 105(10), 1998, pp. 1915-1920
Purpose: To examine the safety of mitomycin C (MMC) use in pediatric g
laucoma surgery. Design: Retrospective interventional case series. Par
ticipants: One hundred eighty pediatric glaucoma patients younger than
7 years of age (254 eyes) who underwent glaucoma surgery and were fol
lowed for at least 1 year participated. Interventions: Surgeries consi
sted of trabeculectomy or combined trabeculotomy-trabeculectomy with a
djunctive use of MMC. Main Outcome Measures: Control of intraocular pr
essure (IOP) and occurrence of complications were measured. An IOP bel
ow 21 mmHg without any additional medical or surgical treatment was co
nsidered a success. Results: Primary congenital glaucoma was present i
n 98% of the patients. Sixty percent had a trabeculectomy, and 40% had
a trabeculotomy-trabeculectomy. The combined surgery was performed mo
stly in infants up to I year of age. Complications were cystic bleb (1
9), bleb leak (4), retinal detachment (3), flat anterior chamber (3),
cataract (2), and endophthalmitis (1), Children younger than 2 years o
f age had fewer complications but higher failure rates. The combined p
rocedure in infants up to 2 years of age was moderately more successfu
l (57%) than trabeculectomy alone (39%), Minimal complications seen in
this group were more likely related to young age than to the type of
surgery. Complications increased with time after surgery, with most oc
curring 2 years or more after surgery. Conclusions: Success of MMC-aug
mented glaucoma filtering surgery increased with age, as did the compl
ication rate. Serious complications were uncommon in the authors' grou
p of pediatric patients up to now. However, complications related to b
leb thinning increased with time after surgery, and additional problem
s can be anticipated with longer follow-up.